complete spinal cord injury
incidence of spinal cord injury
damaged spinal cord
incomplete acute spinal cord injury
different degrees of spinal cord injury
future therapy of spinal cord injuries
multicenter European clinical proof of concept trial Spinal cord injury
cerebro-spinal fluid
traumatic brain injury
tetraplegic patients
enrollment of patients
clinical study
clinical trial design
injuries of brain
nerve fiber growth
fiber regeneration
antibody therapy
placebo-controlled trial
individual quality of life
novel treatment
eventual proof of concept
various degrees of complete
normal life expectancy
improved prediction algorithms of clinical outcomes
growth inhibitory protein Nogo
present study
motor outcome
positive outcome
interrupted nerve fibers
intrathecal application
neuroplasticity
functional recovery
development of surrogate markers
devastating neurological disorder
animal models
axonal sprouting
drug activity
stroke
permanent paralysis
previous phase
multiple sclerosis
Recent preclinical research
social costs
broad patient population
serum
people
efficacy
Advancements
breakthrough
year
unprecedented way
impact
neuroimaging
translation
effectiveness
results
Antibodies